Introduction {#sec1-1}
============

Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by the infiltration of fat in the liver cells. Mainly seen in people who are overweight or obese. NAFLD is seen in the people who are not abused by alcohol. NAFLD initially harmless but leads to liver damage and cirrhosis if the condition gets worse.

High levels of fat in the liver associated with increased risk of diseases like diabetes, high blood pressure and kidney disease, high cholesterol, and metabolic syndrome (MetS).\[[@ref1]\] NAFLD leads to elevated levels of liver enzymes. In western countries, the prevalence rate of NAFLD is 30% whereas in Asia-pacific nations; it is up to 5-30% rises to 80-90% in obese adults, 30-50% in diabetic patients, and 90% in hyperlipidemia. It affects 3-10% of children and 40-70% of obese children.\[[@ref2]\]

Atherosclerosis is a condition characterized by the hardening and narrowing of arteries. It leads to heart attacks, strokes and peripheral vascular diseases together called cardiovascular disease.

Many studies have shown that there is an association between NAFLD and cardiovascular diseases. So, it is important to predict whether NAFLD is an independent predictor of cardiovascular morbidity and mortality.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] Increased carotid intima media thickness (CIMT) is an early indicator of cardiovascular diseases.\[[@ref9][@ref10][@ref11]\] In some studies, mean CIMT ranges from 0.64 ± 0.10 mm to 1.24 ± 0.13 mm in NAFLD patients\[[@ref12]\] carotid atherosclerosis screening should be recommended in all NAFLD patients. Currently available epidemiological data indicate that a value of CIMT at or above 1 mm at any age is associated with a significantly increased risk of myocardial infarction or cerebrovascular disease.\[[@ref11]\]

In our study, we selected a random group of consecutive outpatients and in-patients undergoing abdominal USG. In addition, we evaluated whether any association is independent of classical risk factors and mass features.

Materials and Methods {#sec1-2}
=====================

A total of 90 in-patients and out-patients (45 NAFL subjects and 45 patients with the normal liver as controls) on the abdomen ultrasound scan (USG scan) from the Department of Radiology, Bangalore Baptist Hospital were included in our study. The study was done after obtaining informed consent from the patients and institutional ethical committee clearance.

A detailed history regarding smoking, alcohol consumption, calorie intake, etc., were collected from the patients by administering a questionnaire.

Patients under the age of 65 with normal liver and who do not consume alcohol were included in our study.

Exclusion criteria for both the study and control group {#sec2-1}
-------------------------------------------------------

Patients with any clinical evidence of cirrhosis or other causes of chronic liver disease, History of alcohol consumption, Smoking, Viral hepatitis, Autoimmune hepatitis, Dyslipidemia, Hemochromatosis, Use of hepatotoxic medications (ATT, antiepileptics, and steroids), Type 2 diabetes mellitus.

All the participants were subjected to the doppler study for carotid intima media thickness. An experienced radiologist to prevent variance did the carotid doppler. BMI, height, weight, pulse rate, systolic blood pressure, and diastolic blood pressure were recorded. Blood samples (4 ml) were drawn from all the subjects following a fast of 12 hours and analyzed for Serum Triglycerides (TG), Total cholesterol (TC) and High-density lipoprotein cholesterol (HDL) by enzymatic methods with the help of Glaxo kits on ERBA Chem- 5 semi auto analyzer. Serum Low-density lipoprotein cholesterol (LDL) was calculated by Frederickson-Friedwald\'s formula according to which LDL cholesterol = Total cholesterol - (HDL cholesterol + VLDL cholesterol).

Statistical analysis {#sec2-2}
--------------------

All values expressed as Mean ± standard deviation (SD). An independent *t*-test was used to test the significance of the difference in means between the study group and controls. A Chi-square test for independence is used to determine the relationship between two variables of a sample. A *P* \< 0.05 considered statistically significant. The statistical software namely SPSS 16.0 were used for the analysis of the data and Microsoft word and excel have been used to generate tables.

Results {#sec1-3}
=======

The present study was conducted with 45 NAFL subjects and 45 patients with the normal liver as controls in the department of radiology. The average age of NAFL subjects was 44.87 ± 10.58 years. The oldest subject was 65 years and the youngest being 21 years. Among the study group, 26 were males and 19 were females in NAFLD patients whereas 28 were males and 17 were females in the control group. Height (cm), weight (kg), Body mass index (BMI) (kg/m^2^) and waist circumferences (cm) were compared between NAFLD and control group. Pulse rate (bpm), systolic blood pressure (mmHg), diastole blood pressure (mmHg) were compared with the control group \[[Table 1](#T1){ref-type="table"}\].

###### 

Association between NAFLD and the control group

  Variable                   Group     Mean±SD   *t*     *P*
  -------------------------- --------- --------- ------- ---------
  Height (cm)                Normal    166±8.4   0.873   0.385
  Fatty liver                167±6.9                     
  Weight (kg)                Normal    69±12     3.569   0.001\*
  Fatty liver                77±9.18                     
  BMI                        Normal    25±2.6    3.496   0.001\*
  Fatty liver                27±2.3                      
  Waist circumference (cm)   Normal    87±6.5    0.958   0.341
  Fatty liver                86±7.8                      
  Pulse rate (bpm)           Normal    82±9.1    0.853   0.396
  Fatty liver                80±9.1                      
  Systolic BP (mmHg)         Normal    128±15    0.054   0.95
  Fatty liver                128±22                      
  Diastolic BP (mmHg)        Normal    75±9.3    0.172   0.864
  Fatty liver                76±10                       

\*Statistically significant. NAFLD=Nonalcoholic fatty liver disease, SD=Standard deviation, BMI=Body mass index, bpm=Beats per minute, BP=Blood pressure

[Table 1](#T1){ref-type="table"} depicts mean height in the control group was 166 ± 8.4 cm and the study group was 167 ± 6.9 cm. The mean waist circumference in the control group was 87 ± 6.5 cm and the study group was 86 ± 7.8 cm. In terms of height and waist circumference in relation to NAFLD, there was no statistical significance noted.

The mean BMI in the control group was 25 ± 2.6 kg/m^2^, wherein the study group was 27 ± 2.3 kg/m^2^. There was a significant association between NAFLD and higher BMI in the study group, which was lacking in the control group, with a significant *P* = 0.01.

The mean weight in the control group was 69 ± 12 kg wherein the study group was 77 ± 9.18 kg. The study and the control group were statistically comparable in terms of higher weight associated with NAFLD with a significant *P* = 0.01.

The mean systolic blood pressure (in mm of Hg) in the control group was 128 ± 15 and the study group was 128 ± 22 and diastolic blood pressure (in mm of hg) in the control group was 75 ± 9.3 and study group was 76 ± 10. In terms of systolic and diastolic blood pressures in relation to NAFLD, there was no statistical significance noted.

[Table 2](#T2){ref-type="table"} depicts the control group mean right CIMT (in mm) was 0.54 ± 0.109 whereas in the study group it was 0.62 ± 0.150 and mean left CIMT (in mm) of the control group was 0.53 ± 0.108 whereas in the study group it was 0.65 ± 0.205. The study and the control group were statistically comparable in terms of CIMT in relation to NAFLD with a significant *P* value of 0.05 and 0.01 respectively.

###### 

Association between NAFLD and CIMT

  Variable                  Group        Mean±SD      *t*     *P*
  ------------------------- ------------ ------------ ------- ---------
  Average right CIMT (mm)   Normal       0.54±0.109   2.863   0.005\*
  Fatty liver               0.62±0.150                        
  Average left CIMT (mm)    Normal       0.53±0.108   3.356   0.001\*
  Fatty liver               0.65±0.205                        

\*Statistically significant. NAFLD=Nonalcoholic fatty liver disease, CIMT=Carotid intima media thickness, SD=Standard deviation

[Table 3](#T3){ref-type="table"} depicts the control group mean total cholesterol, HDL, LDL and triglycerides (in mg/dl) was 109 ± 32, 23 ± 8.4, 77 ± 24 and 197 ± 152 and in study group, it was 139 ± 57, 31 ± 13, 98 ± 42 and 169 ± 72 respectively. The study and the control group were statistically comparable in terms of dyslipidemia i.e. higher total cholesterol, HDL, LDL in relation to NAFLD with a significant *P* value of 0.04, 0.01 and 0.01 respectively.

###### 

Association between lipid profile of NAFLD and the control group

  Variable            Group    Mean±SD   *t*     *P*
  ------------------- -------- --------- ------- ---------
  Total cholesterol   Normal   109±32    2.968   0.004\*
  Fatty liver         139±57                     
  HDL                 Normal   23±8.4    3.467   0.001\*
  Fatty liver         31±13                      
  LDL                 Normal   77±24     3.467   0.001\*
  Fatty liver         98±42                      
  Triglycerides       Normal   197±152   1.115   0.268
  Fatty liver         169±72                     

\*Statistically significant. NAFLD=Nonalcoholic fatty liver disease, SD=Standard deviation, HDL=High density lipoprotein cholesterol, LDL=Low density lipoprotein cholesterol

[Table 4](#T4){ref-type="table"} depicts the prevalence of significant CIMT changes is higher in fatty liver subjects (13%) as compared to normal liver subjects (2%), which was statistically significant (*P* = 0.04). The prevalence of fatty liver is more in males (58%) as compared to females (42%).

###### 

Prevalence of significant CIMT in NAFLD

  CIMT       Fatty (*n*=45)   Normal (*n*=45)   Chi-square   *P*
  ---------- ---------------- ----------------- ------------ ---------
  \<0.9 mm   39 (87%)         44 (98%)          3.873        0.049\*
  \>0.9 mm   06 (13%)         01 (2%)                        

\*Statistically significant. CIMT=Carotid intima media thickness, NAFLD=Nonalcoholic fatty liver disease

Discussion {#sec1-4}
==========

The present study includes nondiabetic outpatients and in-patients undergoing abdominal USG assessment for health screening. It was observed that people with fatty liver with or without other features of the metabolic syndrome had significant CIMT. These findings not only support the view of NAFLD as a hepatic manifestation of MetS but also suggest that the hepatic fat accumulation is atherogenic saying that NAFLD has associated carotid artery atherosclerosis and increased cardiovascular morbidity and the risk of strokes. Some studies show that NAFLD is an independent risk factor for cardiovascular disease.\[[@ref13]\] Some hypothetical studies say that NAFLD is not only a marker of cardiovascular disease but may also be involved in its pathogenesis.\[[@ref14]\]

In previous studies, the association between NAFLD and CIMT has currently had already been reported. Targhee *et al*.\[[@ref3]\] found a significant increase in carotid IMT in NAFLD nonobese healthy volunteers whereas in another study, there is an association between NAFLD and carotid IMT concerned only the patients with MetS.\[[@ref8]\]

The following table gives information about 1947 patients Data analysis showed the subject with NAFLD is 35% of pathological CIMT whereas patients without NAFLD, subclinical atherosclerosis was detected as 21.8%, *P* \< 0.0001. Three of the four studies found a relationship between NAFLD and pathological CIMT \[[Table 5](#T5){ref-type="table"}\].

###### 

Studies included in meta-analysis, according to subclinical atherosclerosis

  International studies        Year (of publishing)   Number of patients   NAFLD evaluation   Carotid phenotype   OR score (95% CI)   Country
  ---------------------------- ---------------------- -------------------- ------------------ ------------------- ------------------- -------------
  Kim et al.\[[@ref8]\]        2009                   1021                 Ultrasound         CIMT                2.15 (1.56-2.96)    South Korea
  Wang et al.\[[@ref15]\]      2009                   169                  Ultrasound         CIMT                1.45 (0.67-3.15)    Taiwan
  Kang et al.\[[@ref16]\]      2012                   663                  Ultrasound         CIMT                1.98 (1.14-2.73)    South Korea
  Agarwal et al.\[[@ref17]\]   2011                   179                  Ultrasound         CIMT                2.48 (1.07-5.06)    India

NAFL=Nonalcoholic fatty liver, OR=Odds ratio, CI=Confidence interval, CIMT=Carotid intima media thickness

In our study, there is an elevated level of BMI, weight, dyslipidemia in NAFLD compared with controls \[P = 0.01\] \[[Table 1](#T1){ref-type="table"}\] which is similar to the study of Ji. Hoon Kang *et al*. as he says there is a significantly higher BMI, BP, and liver enzymes C-reactive protein.

In our study, we found NAFLD was independently associated with CIMT \[[Table 2](#T2){ref-type="table"}\]. Those with NAFLD had a higher prevalence of increased CIMT in compassion with controls. These results are supported by previous perspective studies reporting a strong association between NAFLD\[[@ref18][@ref19][@ref20][@ref21]\] and incidence of CID in both diabetic and nondiabetic individuals.\[[@ref22][@ref23][@ref24]\]

In our study, we found the incidence of Metabolic Syndrome was higher in males when compared with females. The relation between NAFLD and MetS has not shown statistically significant.

Our study suggests that cardiovascular risk factors such as increased CIMT occur more frequently among NAFLD patients compared to healthy individuals.

Primary care physicians and specialists have a great role in the management of NAFLD patients with proper care can avoid CVD with the help of measurement of CIM thickness. According to the current scenario, the most common death in NAFLD is CVD^23^. Hence, this study finding would help the primary care physicians to better understanding the role of measurement CIMT can avoid CVD deaths in NAFLD patients. Primary care Physicians and specialists should consider measurement CIMT should consider the best diagnostic method.\[[@ref21]\]

Conclusion {#sec1-5}
==========

We can conclude that NAFLD has a significant association with higher cardiovascular risk in terms of CIMT, Dyslipidemia and Hypoalphalipidemia. We recommend screening of all NAFLD patients for the above risk factors and advise accordingly. Lifestyle changes include weight loss, dietary changes, reduction of sedentary habits and physical exercise are recommended in the NAFLD subjects with higher BMI and weight.
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